Loratadine
Internal ID | 2eed1cd5-0272-4eb9-a634-41efc00067e3 |
Taxonomy | Organoheterocyclic compounds > Benzocycloheptapyridines |
IUPAC Name | ethyl 4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidine-1-carboxylate |
SMILES (Canonical) | CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1 |
SMILES (Isomeric) | CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1 |
InChI | InChI=1S/C22H23ClN2O2/c1-2-27-22(26)25-12-9-15(10-13-25)20-19-8-7-18(23)14-17(19)6-5-16-4-3-11-24-21(16)20/h3-4,7-8,11,14H,2,5-6,9-10,12-13H2,1H3 |
InChI Key | JCCNYMKQOSZNPW-UHFFFAOYSA-N |
Popularity | 4,059 references in papers |
Molecular Formula | C22H23ClN2O2 |
Molecular Weight | 382.90 g/mol |
Exact Mass | 382.1448057 g/mol |
Topological Polar Surface Area (TPSA) | 42.40 Ų |
XlogP | 5.20 |
Atomic LogP (AlogP) | 4.89 |
H-Bond Acceptor | 3 |
H-Bond Donor | 0 |
Rotatable Bonds | 1 |
79794-75-5 |
Claritin |
Alavert |
Loratidine |
Clarityn |
Lisino |
Clarityne |
Loracert |
Loradex |
Bonalerg |
There are more than 10 synonyms. If you wish to see them all click here. |
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9969 | 99.69% |
Caco-2 | + | 0.5491 | 54.91% |
Blood Brain Barrier | + | 1.0000 | 100.00% |
Human oral bioavailability | + | 0.6857 | 68.57% |
Subcellular localzation | Mitochondria | 0.7744 | 77.44% |
OATP2B1 inhibitior | - | 1.0000 | 100.00% |
OATP1B1 inhibitior | + | 0.9139 | 91.39% |
OATP1B3 inhibitior | + | 0.9435 | 94.35% |
MATE1 inhibitior | - | 0.9400 | 94.00% |
OCT2 inhibitior | - | 0.5500 | 55.00% |
BSEP inhibitior | + | 0.9126 | 91.26% |
P-glycoprotein inhibitior | + | 0.8312 | 83.12% |
P-glycoprotein substrate | + | 0.9035 | 90.35% |
CYP3A4 substrate | + | 0.7980 | 79.80% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | - | 0.7948 | 79.48% |
CYP3A4 inhibition | - | 0.8310 | 83.10% |
CYP2C9 inhibition | + | 0.8949 | 89.49% |
CYP2C19 inhibition | + | 0.8994 | 89.94% |
CYP2D6 inhibition | - | 0.9231 | 92.31% |
CYP1A2 inhibition | - | 0.9045 | 90.45% |
CYP2C8 inhibition | + | 0.9818 | 98.18% |
CYP inhibitory promiscuity | + | 0.9359 | 93.59% |
UGT catelyzed | - | 0.0000 | 0.00% |
Carcinogenicity (binary) | - | 0.8100 | 81.00% |
Carcinogenicity (trinary) | Non-required | 0.6408 | 64.08% |
Eye corrosion | - | 0.9886 | 98.86% |
Eye irritation | - | 0.9823 | 98.23% |
Skin irritation | - | 0.7816 | 78.16% |
Skin corrosion | - | 0.9383 | 93.83% |
Ames mutagenesis | - | 0.6637 | 66.37% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.8917 | 89.17% |
Micronuclear | + | 0.6600 | 66.00% |
Hepatotoxicity | - | 0.7625 | 76.25% |
skin sensitisation | - | 0.8185 | 81.85% |
Respiratory toxicity | + | 0.9111 | 91.11% |
Reproductive toxicity | + | 0.8556 | 85.56% |
Mitochondrial toxicity | + | 0.9375 | 93.75% |
Nephrotoxicity | - | 0.6237 | 62.37% |
Acute Oral Toxicity (c) | II | 0.4705 | 47.05% |
Estrogen receptor binding | + | 0.8906 | 89.06% |
Androgen receptor binding | + | 0.8697 | 86.97% |
Thyroid receptor binding | + | 0.7267 | 72.67% |
Glucocorticoid receptor binding | + | 0.6759 | 67.59% |
Aromatase binding | - | 0.5124 | 51.24% |
PPAR gamma | + | 0.6681 | 66.81% |
Honey bee toxicity | - | 0.9344 | 93.44% |
Biodegradation | - | 0.8250 | 82.50% |
Crustacea aquatic toxicity | + | 0.5189 | 51.89% |
Fish aquatic toxicity | + | 0.9905 | 99.05% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL2903 | P16050 | Arachidonate 15-lipoxygenase |
25118.9 nM |
Potency |
via CMAUP
|
CHEMBL2047 | Q96RI1 | Bile acid receptor FXR |
3070 nM |
IC50 |
PMID: 23688559
|
CHEMBL1293237 | P54132 | Bloom syndrome protein |
28183.8 nM 28183.8 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL4096 | P04637 | Cellular tumor antigen p53 |
31622.8 nM 25118.9 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL3622 | P33261 | Cytochrome P450 2C19 |
2800 nM 16 nM |
IC50 IC50 |
PMID: 22328583
via CMAUP |
CHEMBL3721 | P10632 | Cytochrome P450 2C8 |
2950 nM |
IC50 |
PMID: 22328583
|
CHEMBL3397 | P11712 | Cytochrome P450 2C9 |
39.8 nM 15848.9 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL289 | P10635 | Cytochrome P450 2D6 |
<
100 nM |
IC50 |
PMID: 22328583
|
CHEMBL340 | P08684 | Cytochrome P450 3A4 |
6309.6 nM 6309.6 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1293278 | O75496 | Geminin |
31622.8 nM |
Potency |
via CMAUP
|
CHEMBL240 | Q12809 | HERG |
169.82 nM 173 nM 169.82 nM 169.82 nM 169.82 nM 173.78 nM 173.78 nM |
IC50 IC50 IC50 IC50 IC50 IC50 IC50 |
via Super-PRED
PMID: 12190308 PMID: 12873512 PMID: 15911273 PMID: 18448342 PMID: 21185626 PMID: 19110341 |
CHEMBL231 | P35367 | Histamine H1 receptor |
170 nM 290 nM |
IC50 IC50 |
via CMAUP
PMID: 16220969 |
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha |
15848.9 nM 15848.9 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL4040 | P28482 | MAP kinase ERK2 |
19952.6 nM |
Potency |
via CMAUP
|
CHEMBL1293224 | P10636 | Microtubule-associated protein tau |
10000 nM 25118.9 nM 12589.3 nM 28183.8 nM 35481.3 nM |
Potency Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via CMAUP via CMAUP |
CHEMBL5162 | Q6W5P4 | Neuropeptide S receptor |
7943.3 nM 12589.3 nM 3981.1 nM |
Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP |
CHEMBL4302 | P08183 | P-glycoprotein 1 |
11400 nM |
IC50 |
PMID: 11454724
|
CHEMBL1293298 | Q01453 | Peripheral myelin protein 22 |
42561.5 nM |
Potency |
via CMAUP
|
CHEMBL3401 | O75469 | Pregnane X receptor |
10000 nM 10000 nM 12600 nM |
EC50 EC50 EC50 |
PMID: 20966043
PMID: 20966043 PMID: 20966043 |
CHEMBL1293235 | P02545 | Prelamin-A/C |
11220.2 nM 31622.8 nM 15848.9 nM 22387.2 nM |
Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via CMAUP |
CHEMBL2842 | P42345 | Serine/threonine-protein kinase mTOR |
23280.9 nM |
Potency |
via CMAUP
|
CHEMBL1833 | P41595 | Serotonin 2b (5-HT2b) receptor |
245 nM |
IC50 |
via CMAUP
|
CHEMBL3351189 | Q9H2J7 | Sodium-dependent neutral amino acid transporter B(0)AT2 |
4000 nM |
IC50 |
PMID: 25318072
|
CHEMBL1293232 | Q16637 | Survival motor neuron protein |
31622.8 nM 11220.2 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1293256 | P40225 | Thrombopoietin |
19952.6 nM 19952.6 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1963 | P16473 | Thyroid stimulating hormone receptor |
19952.6 nM 39810.7 nM 19952.6 nM 39810.7 nM |
Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via CMAUP |
CHEMBL1293227 | O75604 | Ubiquitin carboxyl-terminal hydrolase 2 |
12589.3 nM |
Potency |
via CMAUP
|
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.58% | 96.09% |
CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 97.40% | 95.17% |
CHEMBL2581 | P07339 | Cathepsin D | 96.77% | 98.95% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 95.77% | 86.33% |
CHEMBL3691 | Q13822 | Autotaxin | 94.26% | 96.39% |
CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 93.95% | 94.00% |
CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 92.90% | 93.10% |
CHEMBL2094127 | P06493 | Cyclin-dependent kinase 1/cyclin B | 92.02% | 96.00% |
CHEMBL2047 | Q96RI1 | Bile acid receptor FXR | 91.28% | 96.10% |
CHEMBL4208 | P20618 | Proteasome component C5 | 91.01% | 90.00% |
CHEMBL2378 | P30307 | Dual specificity phosphatase Cdc25C | 89.49% | 96.67% |
CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 88.69% | 90.24% |
CHEMBL1951 | P21397 | Monoamine oxidase A | 88.48% | 91.49% |
CHEMBL5409 | Q8TDU6 | G-protein coupled bile acid receptor 1 | 87.27% | 93.65% |
CHEMBL5339 | Q5NUL3 | G-protein coupled receptor 120 | 86.98% | 95.78% |
CHEMBL2335 | P42785 | Lysosomal Pro-X carboxypeptidase | 86.54% | 100.00% |
CHEMBL3401 | O75469 | Pregnane X receptor | 85.51% | 94.73% |
CHEMBL6007 | O75762 | Transient receptor potential cation channel subfamily A member 1 | 83.74% | 92.17% |
CHEMBL5028 | O14672 | ADAM10 | 82.53% | 97.50% |
CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 82.07% | 95.89% |
CHEMBL2146302 | O94925 | Glutaminase kidney isoform, mitochondrial | 81.62% | 100.00% |
CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 81.29% | 96.00% |
CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 81.13% | 98.33% |
CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 80.38% | 90.71% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 80.34% | 99.17% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Sesamum indicum |